Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SUNOSI® (Solriamfetol) Pregnancy Registry: An Observational Study on the Safety of Solriamfetol Exposure in Pregnant Women and Their Offspring

NCT06413420 is registered in ClinicalTrials.gov with Axsome Therapeutics, Inc. as lead sponsor.

NCT NCT06413420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06413420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SUNOSI® (Solriamfetol) Pregnancy Registry: An Observational Study on the Safety of Solriamfetol Exposure in Pregnant Women and Their Offspring
Lead sponsor
Axsome Therapeutics, Inc.
Phase
Observational
Overall status
Recruiting
Start date
July 31, 2019
Completion date
September 30, 2029
Enrollment
1,731 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

narcolepsy, obstructive sleep apnea, pregnant women and their offspring